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Larsen LE, Tegtmeier C, Pedersen E: Bovine respiratory syncytial virus (BRSV)
pneumonia in beef calf herds despite vaccination. Acta vet. scand. 2001, 42, 113-
121. – The present report describes the clinical, pathological, serological and virologi-
cal ﬁndings in calves from 2 larger Danish beef herds experiencing outbreaks of pneu-
monia. The calves had been vaccinated with an inactivated bovine respiratory syncytial
virus (BRSV) vaccine 2 months prior to the outbreak. The clinical signs comprised na-
sal discharge, pyrexia, cough and increased respiratory rates. A total of 28 calves died
in the 2 herds. The laboratory investigations revealed that BRSV was involved and prob-
ably initiated both outbreaks. Furthermore, the serological results suggested that the
vaccine induced only sparse levels of antibodies probably due to the presence of mater-
nally derived antibodies at the time of vaccination. Necropsy ﬁndings in 5 calves re-
vealed changes typical for infectious pneumonia with involvment of BRSV. In conclu-
sion, vaccination of calves against BRSV in 2 Danish beef herds failed to protect the
calves against severe or even fatal BRSV mediated respiratory disease 2 months later.
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Introduction
Respiratory disease is one of the most impor-
tant health problems in young Danish cattle
with substantial ﬁnancial losses for the industry
(Tegtmeier et al. 1999, Uttenthal et al. 1996).
Thus, approximately 20% of the materials from
bovines submitted to The Danish Veterinary
Laboratory (DVL) for necrosy originate from
cattle with a history of respiratory symptoms.
Bovine respiratory syncytial virus (BRSV) has
been recognised in recent years as the major vi-
ral component of the bovine respiratory disease
(BRD) complex (Larsen 2000). This is based
on the high prevalence of seropositive individu-
als (Uttenthal et al. 2000, Uttenthal et al. 1996)
and the strong correlation between respiratory
disease and detection of the virus in diagnostic
samples (Larsen et al. 1999). BRSV has a pred-
ilection for the lower respiratory tract and may
damage the respiratory tract epithelium directly
followed by changes induced by, i.e. inﬂamma-
tory mediators (Kimman et al. 1989a) and/or it
may increase the ability of bacteria to invade
the lung and cause a secondary bacterial infec-
tion (Babiuk et al. 1988). So far it has not been
possible to prove a clear link between protec-
tion and level of actively produced or passively
acquired antibodies in natural BRSV infection.
Thus, calves less that 6 months are most fre-
quently infected with BRSV despite the pres-
ence of maternally derived antibodies. Further-
more, reinfections occur even in sero-positive
calves (Van der Poel et al. 1993). Antibodies
may be partly protective, however, since the in-
cidence and severity of disease seems to be in-
versely related to the level of speciﬁc maternal
antibodies (Kimman et al. 1988). Several inac-tivated and modiﬁed live BRSV vaccines are
commercially available in North-America and
Europe, yet none have been registered for use in
Denmark (September, 2000). In 1997 approxi-
mately 20 Danish beef herds, with conﬁrmed
BRSV positive status, received a temporary
permission to use an inactivated vaccine against
BRSV in calves. The present report describes
the clinical, pathological, serological and viro-
logical ﬁndings in vaccinated calves in 2 Dan-
ish beef herds experiencing outbreaks of pneu-
monia in January 1998.
Materials and methods
Herds and animals
Two beef cattle herds, each producing approxi-
mately 1000 calves a year were included. In
herd A, new calves, aged 2-4 weeks were pur-
chased from different sources every second
month. The calves were reared in groups in 2
different housing systems: An indoor-system
where the calves were kept in groups of 45 and
an outdoor system where the calves were kept
in groups of 15 in calf hutches. In herd B, the
calves were purchased and reared as described
for herd A. After 5-6 months, however, the
calves from this herd were transferred to a sep-
arate farm nearby and kept there in a tradition-
ally indoor system and slaughtered at 7-9
months of age. The veterinarian described the
management in both farms as “excellent”.
Vaccine and vaccination
According to the speciﬁcations supplied by the
vendor, each 2-ml dose of the betapropiolac-
tone-inactivated vaccine contained at least 0.80
SN.U (1 SN.U is the quantity necessary to ob-
tain 1 log10 sero-neutralising antibodies in the
guinea-pig) of inactivated BRSV in aluminium
hydroxychloride and saponin adjuvant.
In both herds all calves received 2 subcutane-
ous vaccinations (2 ml per calf per vaccination),
4 and 7 weeks after arrival, respectively accord-
ing to the manufacture’s guidelines. The vacci-
nation program was ﬁnalised December the 1st
1997.
Clinical signs and treatments
All calves were inspected daily for signs of dis-
ease. On indication, the rectal temperature was
measured (data not shown). In the case of clin-
ical signs or increased rectal temperature the
veterinarian inspected the calves and eventually
initiated treatment with antibiotics. 
Sampling
Nasal swabs for virology and plain blood sam-
ples for serology were taken from 10 calves
with clinical signs of respiratory disease in each
of the 2 herds as previously described (Utten-
thal et al. 1996). A second blood sample was
taken 3-4 weeks later from the same calves.
Necropsy and microbiology
Five dead calves in herd B were necropsied on
location. The macroscopic ﬁndings were re-
corded and the lungs transported to the DVL
where bacteriological and mycoplasma exam-
ination, and histological processing was per-
formed as previously described (Tegtmeier et
al. 1999). For virology, material from the ne-
cropsied calves and nasal swabs were tested for
the presence of BRSV, bovine corona virus
(BCV), bovine parainﬂuenza-3 (PI-3) virus,
and bovine viral diarrhoea virus (BVDV) by
antigen ELISA as previously described (Utten-
thal et al. 1996, Meyling 1982). Tests for infec-
tious bovine rhinotracheitis (IBR) virus are not
routinely performed since Denmark is consid-
ered free from this infection.
Serology
The serum samples were tested for the presence
of speciﬁc antibodies against BRSV, including
IgG1, IgG2, IgM and IgA isotypes and BRSV
neutralising serum antibodies (SNT) as de-
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dition, the paired serum samples were tested for
antibodies against BCV and PI-3 as previously
described (Uttenthal et al. 1996).
Results
Clinical signs and treatments
No adverse effects were seen in any of the
calves in the 2 herds following vaccination.
In both herds, severe outbreaks of respiratory
disease started in January 1998. The clinical
signs comprised nasal discharge, pyrexia,
coughing, elevated respiratory rates and
marked depression. Almost all calves between
4 and 7 months of age were more or less af-
fected and a total of 8/500 and 20/250 calves
died during the outbreak in herd A and B, re-
spectively. The outbreak ceased within 2 weeks
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Table 1. Virological and serological ﬁndings in vaccinated calves during acute outbreak of respiratory disease in herd
A (a) and herd B (b). Nasal swabs were taken at the acute phase (20/26 Jan) and paired serum samples were taken at the
acute phase and one month later (18/19 Feb). The nasal swabs were analysed for the presence of bovine respiratory syn-
cytial virus (BRSV), bovine corona virus (BCV) and parainﬂuenza-3 virus (PI-3) antigen (Ag) by ELISA. Serum sam-
ples were analysed for the presence of antibodies against BRSV (IgM, IgA, IgG1, IgG2 isotypes) and neutralising anti-
bodies (SNT), BCV (Ab) and PI-3 (Ab). Signiﬁcant change in antibody titers were deﬁned as either sero-conversion
(from 0 to any titer) or at least four-fold rises. Dead: The calf died between the two sampling dates. NA: Not applicable.
* Insufﬁcient amount of sample for testing.
Table 1a
BRSV Ag BRSV-IgM BRSV-IgA BRSV-IgG1 BRSV-IgG2 BRSV-SNT
Calf # 20 Jan 20 Jan 19 Feb 20 Jan 19 Feb 20 Jan 19 Feb Rise 20 Jan 19 Feb Rise  20 Jan 19 Feb Rise
332 + 0 Dead 0 Dead 0 Dead NA 0 Dead NA 64 Dead NA
338R 0 0 0 0 40 80 2560 YES 0 2560 YES 16 2048 YES
325 + 0 * 0 0 40 160 YES 0 * NA 16 1024 YES
340 0 0 0 0 20 160 1280 YES 40 2560 YES 64 256 YES
244N 0 0 Dead 0 Dead 40 Dead NA 0 Dead NA 8 Dead NA
416 0 0 0 0 20 20 2560 YES 0 640 YES 4 128 YES
421H 0 0 0 0 160 20 160 YES 0 10240 YES 16 2048 YES
426H 0 0 0 0 0 40 160 YES 40 160 YES 256 32 No
407H 0 0 0 0 0 0 320 YES 0 1280 YES 2 1024 YES
436H 0 0 0 0 0 40 5120 YES 0 40 YES 8 2048 YES
BCV Ag BCV Ab PI-3 Ag PI-3 Ab
Calf # 20 jan 20 Jan 19 Feb Rise 20 Jan 20 Jan 19 Feb Rise
332 0 800 Dead NA 0 0 Dead NA
338R 0 12800 12800 NO 0 0 0 NO
325 0 1600 3200 NO 0 8 8 NO
340 0 3200 1600 NO 0 8 8 NO
244N 0 3200 Dead NA 0 8 Dead NA
416 0 1600 1600 NO 0 0 0 NO
421H 0 3200 3200 NO 0 0 0 NO
426H 0 800 6400 YES 0 0 0 NO
407H 0 1600 1600 NO 0 0 0 NO
436H 0 3200 6400 NO 0 0 0 NOin both herds, however prolonged treatments
(primarily antibiotics) of few severe affected
calves were necessary for additional 1-2 weeks. 
Laboratory ﬁndings
Herd A
The results of the virological and serological
analysis are detailed in Table 1a. BRSV antigen
was detected in nasal swabs from 2 out of 10
sampled animals of which one died. None of
the tested calves had IgM or IgA antibodies
against BRSV at the ﬁrst sampling day, whereas
4 out of 8 calves had moderate levels of IgA one
month later. The initial IgG1 titers were low
(between 0 and 160) increasing to titers 160-
5120 one month later. IgG2 was absent in 8 out
of 10 calves at the ﬁrst sampling and low (titer
40) in the remaining 2 calves, however the titers
increased to very high titers at the second sam-
pling (up to 10240). Thus, all surviving calves
had signiﬁcant titer rise in BRSV speciﬁc IgG1
and IgG2 antibodies between the 2 samplings.
Similarly, the level of neutralising antibodies
(SNT) increased from rather low to very high
titers (up to 2048) in all but one calf between
the 2 samplings. BCV or PI-3 antigen were not
detected in any of the calves and only one calf
had signiﬁcant rise in BCV speciﬁc antibodies
between the 2 samplings. None of the calves
showed rise in PI-3 speciﬁc antibodies. 
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Table 1b
BRSV Ag BRSV-IgM BRSV-IgA BRSV-IgG1 BRSV-IgG2 BRSV-SNT
Calf # 26 Jan 26 Jan 18 Feb 26 Jan 18 Feb 26 Jan 18 Feb Rise 26 Jan 18 Feb Rise  26 Jan 18 Feb Rise
1064/5 0 0 0 * 40 *≥1280 10240 NA * 5120 NA 64 2048 YES
2535/5 0 0 Dead 80 Dead 2560 Dead NA 80 Dead NA 2048 Dead NA
2537/5 0 0 0 0 0 320 320 NO 0 320 YES 128 256 NO
642/5 0 0 Dead 0 Dead 1280 Dead NA 0 Dead NA 64 Dead NA
829/5 0 640 0 80 20 640 160 NO 20 160 YES 64 32 NO
1057 0 0 0 0 0 1280 2560 NO 0 640 YES 256 128 NO
821 0 0 Dead 80 Dead 1280 Dead NA 20 Dead NA 2048 Dead NA
799 0 0 Dead 0 Dead 320 Dead NA 0 Dead NA 64 Dead NA
795 0 320 Dead 80 Dead 5120 Dead NA 0 Dead NA 1024 Dead NA
1317 0 0 0 0 20 640 2560 YES 20 160 YES 8 148 YES
BCV Ag BCV Ab PI-3 Ag PI-3 Ab
Calf # 26 jan 26 Jan 18 Feb Rise 26 Jan 26 Jan 18 Feb Rise
1064/5 0 * ≥25600 NA 0 * 0 NA
2535/5 0 6400 Dead NA 0 0 Dead NA
2537/5 0 3200 12800 YES 0 0 0 NO
642/5 0 800 Dead NA 0 0 Dead NA
829/5 0 800 ≥25600 YES 0 0 8 YES
1057 0 1600 ≥25600 YES 0 0 0 NO
821 0 6400 Dead NA 0 16 Dead NA
799 0 3200 Dead NA 0 0 Dead NA
795 0 3200 Dead NA 0 8 Dead NA
1317 0 12800 12800 NO 0 8 0 NOHerd B
The results of the virological and serological
analysis are detailed in table 1b. No virus spe-
ciﬁc antigen was detected in nasal swabs from
any of the 10 sampled animals. As 5 of the 10
calves died between the 2 sampling days, paired
serum samples were available from only 5
calves. Four of the 10 tested calves had IgM
and/or IgA antibodies against BRSV at the ﬁrst
sampling day. In addition, 3 out of 5 calves had
low levels of IgA one month later including the
2 calves that were IgA negative at the ﬁrst
sampling. The initial IgG1 titers were high
(between 320 and 5120) and only one calf out
of 5 had signiﬁcant rise in IgG1 titers between
the 2 samplings. IgG2 was present in low levels
in only 4 out of 10 calves at the ﬁrst sampling
and increased to moderate to high titers at the
second sampling in all calves tested. The level
of neutralising antibodies (SNT) varied be-
tween titer 8 and 2048 at the ﬁrst sampling and
increased in only two calves, which had initial
low titers. There was no clear correlation
between level of BRSV speciﬁc antibodies in
the initial sample and the fate of the calf, i.e.
calves with low as well as high SNT titers died
between the 2 sampling days. Three out of 5
calves had signiﬁcant rise in BCV speciﬁc anti-
bodies between the 2 samplings. One of the
calves seroconverted to PI-3 virus (titer 0 → 8).
At necropsy, acute bronchopneumonia charac-
terized by red consolidated tissue, interstitial
edema and marked interstitial emphysema was
observed in all 5 cases. The results of the histo-
pathological and microbiological ﬁndings are
summarized in Table 2. Mannheimia (Pasteu-
rella) haemolytica (M. haemolytica), Myco-
plasma dispar (M. dispar), Mycoplasma bo-
virhinis (M. bovirhinis), Mycoplasma bovis (M.
bovis) and Ureaplasma diversum (U. diversum)
was isolated either alone or concomitantly from
one or more of the 5 cases. Histological exam-
inations revealed a ﬁbrinous-necrotizing pneu-
monia in 2 cases whereas the remaining three
cases were diagnosed as suppurative broncho-
pneumonias. In all cases, variable numbers of
syncytial cells were seen.
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Table 2. Results of post mortem diagnostic examinations of lungs from ﬁve calves that died during the out-
break in herd B. The lungs were examined macroscopic and microscopic and samples were tested for the pres-
ence of bacteria, mycoplams and virus. 
Animal ID Virus Bacteria Mycoplasm Histopathology
1408 Negative M. haemolytica U. diversum Fibrino-necrotizing
M. dispar bronchopneumonia
2131 Negative M. haemolytica U. diversum Fibrino-necrotizing
M. bovirhinis bronchopneumonia
1083 BRSV No bacterial U. diversum Suppurative 
pathogens isolated bronchopneumonia
0782 BRSV No bacterial U. diversum Suppurative 
pathogens isolated M. bovis bronchopneumonia
1004 Negative No bacterial U. diversum Suppurative 
pathogens isolated bronchopneumonia
M. haemolytica: Mannheimia haemolytica; M. dispar: Mycoplasms dispar, M. bovis: Mycoplasms bovis, M. bo-
virhinis: Mycoplasms bovirhinis, U.diversum: Ureaplasma diversum.Discussion
The detection of BRSV antigen in 2 calves, and
the serological responses in the majority of
calves strongly indicated that BRSV was in-
volved in the outbreak in herd A. Similarly, the
presence of BRSV antigen in 2 of the necrop-
sied calves, and the serological responses sug-
gested that this was also true for the outbreak in
herd B.
Previous studies on the pathogenesis of BRSV
infection have shown that BRSV antigen may
be detected in nasal swabs material from days
2-3 until days 8-10 post infection (Larsen et al.
1999, Vilcek et al. 1994). Studies on the kine-
tics of BRSV speciﬁc antibody isotypes in
serum have revealed that IgM and IgA may be
present from day 8-10 until days 14-25 (Kim-
man et al. 1988). IgG1 being detectable from
days 10-17, peaking on days 24-38 and remain-
ing detectable for up to 8 months (half-life 21-
32 days) (Schrijver et al. 1996, Kimman et al.
1988). The IgG2 isotype did not appear in
serum until days 25-86, peaking on days 38-90
and lasting for at least 9 months. Thus, the de-
tection of antigen in the nasal cavity and the
lack of IgM and IgA at the ﬁrst sampling in
herd A indicated these samples were taken
shortly after infection, i.e. prior to day 8-10. 
Contrary to the situation in herd A, the lack of
antigen in nasal swabs and the presence of IgM
and IgA in herd B indicated that the ﬁrst sam-
ples were taken later than 8-12 days after infec-
tion. At this time detectable amounts of IgG1
and SNT antibodies may have been produced in
response to the active infection, especially in
vaccinated calves (see below). The relatively
high titers of IgG1 and SNT encountered in
herd B at the ﬁrst sampling do not necessarily
represent antibodies induced by the vaccine.
Similarly, the low IgG1 and SNT titers at the
ﬁrst sampling in herd A may represent either
residues of maternal derived antibodies or anti-
bodies induced by the vaccine. 
Whatsoever, the low titers indicated either that
the vaccine induced only low levels of antibod-
ies or that these had vanished by the time of
sampling (approximately 2 months after last
vaccination). The failure of the vaccine to in-
duce higher titers of antibodies may be due to
either poor immunigenicity or the presence of
moderate or high levels of maternally derived
antibodies at the time of vaccination. Thus,
presence of maternally or naturally acquired
antibodies have been shown to suppress both
the local and systemic antibody responses fol-
lowing experimental BRSV infection (Ciszew-
ski et al. 1991, Kimman et al. 1987). Interest-
ingly, these studies also revealed that a memory
response might be mounted even in the absence
of a detectable primary response in seropositive
calves. Therefore, vaccinated calves may dis-
play a stronger and more rapid systemic anti-
body response at challenge. Indeed, the high
IgG1, IgG2 and SNT titers in the second sam-
ple in both herds were in surplus of the titers
normally seen in naturally infected calves (Ut-
tenthal et al. 2000). 
Published ﬁeld trials, with live or inactivated
BRSV vaccines, revealed different levels of
protection (Fulton et al. 1995, Kubota et al.
1992,  Howard et al. 1987,  Verhoeff & van
Nieuwstadt 1984, Mohanty et al. 1981) while
others found that vaccination enhanced disease
in calves (Gershwin et al. 1998, Kimman et al.
1989b). Kimman and co-workers investigated
the effect of routes of administration and mater-
nal antibodies on the protective effect of modi-
ﬁed live and inactivated vaccines (Kimman et
al. 1989c). Intramuscular administration, espe-
cially in calves that possessed maternal anti-
bodies, proved least effective in inducing pro-
tection and intranasal inoculation of live virus
in colostrum deprived calves proved most ef-
fective. 
Multiple infectious agents: M. haemolytica, M.
dispar, M. bovirhinis, M. bovis and U. diversum
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in addition to the BRSV antigen detected in 2
cases. These ﬁndings were in accordance with
previous microbiological studies on pneumonic
calf lung tissue, where multiple pathogens fre-
quently were isolated (Tegtmeier et al. 1999).
The presence of one or more of the isolated mi-
croorganisms may likely have contributed to
the development and severity of pneumonia.
However, viral agents, such as BRSV, are usu-
ally considered the primary pulmonary patho-
gen, capable of destroying the respiratory epi-
thelial lining to a degree allowing other agents
to colonize (Babiuk et al. 1988). In a former
study (Tegtmeier et al. 1999), performed on
pneumonic lung tissue submitted to the DVL
for diagnostic purposes, BRSV antigen was of-
ten detected in cases of suppurative bronchop-
neumonias, in which syncytial cells and inter-
stitial emphysema could be observed. Syncytial
cells and interstitial emphysema were features
present in all 5 cases necropsied in the present
study, thereby indicating that BRSV was, or had
been, present in the examined lungs. 
The signiﬁcant rise in BCV speciﬁc antibodies
in 3 out of 5 calves in herd B and the presence
of high titers of BCV antibodies in most of the
other sampled calves in both herds conﬁrm pre-
vious ﬁndings, that BCV is common in Danish
cattle (Larsen et al. 1999). However, the associ-
ation between the presence of BCV and BCV
antibodies and outbreak of respiratory disease
is still controversial (Martin et al. 1998). Ex-
perimental infections with BCV failed to in-
duce fulminate respiratory disease (Heckert et
al. 1991), but the detection of BCV in nasal
swabs and speciﬁc rise in BCV titers were
strongly correlated to outbreaks of respiratory
disease in a large survey recently performed in
20 Danish dairy herds (Alban et al. 1999).
Thus, presently BCV may be considered in-
volved in the BRD complex, but the virus is
probably not capable of inducing fulminate res-
piratory disease without the presence of other
contributing factors. Interpretation of BCV ser-
ological and virological data is further compli-
cated by the fact that the diagnostic assays em-
ployed did not distinguish between BCV strains
involved in BRD and strains involved in enteric
infections.
In conclusion, the data obtained in the present
investigation strongly indicated that BRSV was
involved, and probably initiated, both outbreaks
of BRD despite prior vaccination with an inac-
tivated BRSV vaccine. The company withdrew
the vaccine from the European marked in the
early spring of 1998.
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Bovin Respiratorisk Syncyticel Virus (BRSV) lunge-
betændelse i slagtekalvebesætninger på trods ad vac-
cination.
Artiklen beskriver de kliniske, patologiske, serolo-
giske og virologiske fund i kalve fra 2 større danske
slagtekalvebesætninger i forbindelse med udbrud af
alvorlig lungebetændelse. Kalvene var vaccineret
med en inaktiveret vaccine mod bovine respiratorisk
syncytial virus (BRSV) to måneder tidligere. De kli-
niske symptomer omfattede nasal ﬂåd, feber, hoste
og forøget respirationsfrekvens. I alt 28 kalve døde i
de to besætninger. Laboratorieundersøgelser viste at
BRSV var involveret og formodentligt udløste begge
udbrud. Ydermere viste resultaterne af de serolo-
giske tests, at vaccinen kun inducerede lave mængder
af antistoffer; formodentlig på grund af tilstede-
værelse af maternelle antistoffer på vaccinations-
tidspunktet. Obduktion af fem kalve viste foran-
dringer typisk for lungebetændelse forårsaget af
BRSV. På baggrund af de beskrevne fund kunne det
konkluderes, at vaccination med en inaktiveret
BRSV vaccine ikke beskyttede kalvene mod alvorlig
og fatal lungebetændelse to måneder efter sidste vac-
cination.
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